Recent Insider Transactions - ArriVent BioPharma (NASDAQ: AVBP)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ AVBP ArriVent BioPharma

HILLHOUSE INVESTMENT MANAGEMENT, LTD. / 10 percent owner

01/30/2024

Buy

$18.00

555,555

$10.000M

4.48M

NASDAQ AVBP ArriVent BioPharma

ORBIMED ADVISORS LLC / director, 10 percent owner:

01/30/2024

Buy

$18.00

222,222

$4.000M

1.51M

NASDAQ AVBP ArriVent BioPharma

GORDON CARL L / director, 10 percent owner:

01/30/2024

Buy

$18.00

222,222

$4.000M

1.51M

NASDAQ AVBP ArriVent BioPharma

HEALY JAMES / director

01/30/2024

Buy

$18.00

444,444

$8.000M

1.70M

NASDAQ AVBP ArriVent BioPharma

Nolet Chris / director

01/25/2024

Buy

$18.00

17,884

$322K

17,884

NASDAQ AVBP ArriVent BioPharma

Nolet Chris / director

01/25/2024

Sell

$6.24

16,436

$103K

NASDAQ AVBP ArriVent BioPharma

Kung Winston / officer: Chief Financial Officer

01/25/2024

Sell

$7.76

197,238

$1.531M

NASDAQ AVBP ArriVent BioPharma

Kastenmayer James Paul / officer: General Counsel

01/25/2024

Sell

$6.24

65,745

$410K

NASDAQ AVBP ArriVent BioPharma

Kastenmayer James Paul / officer: General Counsel

01/25/2024

Sell

$7.76

32,873

$255K